Security
Cyteir Therapeutics Inc. Common Stock · CYT
CYTNASDAQCommon stockHistorical · closed Mar 15, 2024CIK 1662244Updated Nov 16, 2026
CYT price & chart
Historical security
This listing closed Mar 15, 2024. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| ASSETS | |||
| AssetsUSD | 153,232,000Source | 195,388,000Source | 13,735,000Source |
| Property, Plant and Equipment, NetUSD | 1,699,000Source | 2,055,000Source | 1,287,000Source |
| Current assets: | |||
| Cash and Cash Equivalents, at Carrying ValueUSD | 147,120,000Source | 189,723,000Source | 10,938,000Source |
| Assets, CurrentUSD | 149,209,000Source | 193,077,000Source | 12,131,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 2,089,000Source | 3,354,000Source | 1,193,000Source |
| Operating Lease, Right-of-Use AssetUSD | 2,066,000Source | — | — |
| Other Assets, NoncurrentUSD | 2,324,000Source | 256,000Source | 317,000Source |
| LIABILITIES AND EQUITY | |||
| LiabilitiesUSD | 6,946,000Source | 8,096,000Source | 4,355,000Source |
| Stockholders’ equity: | |||
| Common Stock, Value, IssuedUSD | 35,000Source | 35,000Source | 2,000Source |
| Retained Earnings (Accumulated Deficit)USD | -138,114,000Source | -92,053,000Source | -49,927,000Source |
| Stockholders' Equity Attributable to ParentUSD | 146,286,000Source | 187,292,000Source | -48,031,000Source |
| Additional Paid in Capital, Common StockUSD | 284,365,000Source | 279,310,000Source | 1,894,000Source |
| Liabilities and EquityUSD | 153,232,000Source | 195,388,000Source | 13,735,000Source |
| Current liabilities: | |||
| Liabilities, CurrentUSD | 5,315,000Source | 7,511,000Source | 3,137,000Source |
| Operating Lease, Liability, CurrentUSD | 889,000Source | — | — |
| Accounts Payable, CurrentUSD | 1,128,000Source | 1,785,000Source | 1,689,000Source |
| Operating Lease, Liability, NoncurrentUSD | 1,560,000Source | — | — |
| Other Liabilities, NoncurrentUSD | 1,631,000Source | 201,000Source | 766,000Source |
cash flow · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -46,061,000Source | -42,126,000Source | -20,823,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Depreciation, Depletion and AmortizationUSD | 668,000Source | 479,000Source | 351,000Source |
| Changes in operating assets and liabilities: | |||
| Increase (Decrease) in Accounts PayableUSD | -657,000Source | 38,000Source | 1,027,000Source |
| Deferred Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -42,532,000Source | -36,032,000Source | -18,539,000Source |
| Cash flows from investing activities: | |||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -312,000Source | -1,189,000Source | -850,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 312,000Source | 1,189,000Source | 850,000Source |
| Cash flows from financing activities: | |||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 242,000Source | 216,006,000Source | 1,427,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -42,602,000Source | 178,785,000Source | -17,962,000Source |
| Additional Financial Items | |||
| Share-based Payment Arrangement, ExpenseUSD | 4,682,000Source | 3,465,000Source | 467,000Source |
| General and Administrative ExpenseUSD | 13,546,000Source | 11,300,000Source | 4,178,000Source |
| Net Income (Loss) Attributable to ParentUSD | -46,061,000Source | -42,126,000Source | -20,823,000Source |
| Nonoperating Income (Expense)USD | 2,109,000Source | 133,000Source | 120,000Source |
| Operating ExpensesUSD | 48,170,000Source | 42,259,000Source | 20,943,000Source |
| Other Nonoperating Income (Expense)USD | 2,109,000Source | 133,000Source | 120,000Source |
| Proceeds from Issuance of Common StockUSD | 64,000Source | — | — |
| Proceeds from Stock Options ExercisedUSD | 178,000Source | 231,000Source | 661,000Source |
income statement · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Operating Income (Loss)USD | -48,170,000Source | -42,259,000Source | -20,943,000Source |
| Other Nonoperating Income (Expense)USD | 2,109,000Source | 133,000Source | 120,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -46,034,000Source | -42,129,000Source | -20,800,000Source |
| Net Income (Loss) Attributable to ParentUSD | -46,061,000Source | -42,126,000Source | -20,823,000Source |
| Earnings Per Share, BasicUSD per share | -1.31Source | — | — |
| Earnings Per Share, DilutedUSD per share | -1.31Source | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 35,272,831Source | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 35,272,831Source | — | — |
| Additional Financial Items | |||
| General and Administrative ExpenseUSD | 13,546,000Source | 11,300,000Source | 4,178,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -46,034,000Source | -42,129,000Source | -20,800,000Source |
| Nonoperating Income (Expense)USD | 2,109,000Source | 133,000Source | 120,000Source |
| Operating ExpensesUSD | 48,170,000Source | 42,259,000Source | 20,943,000Source |
| Research and Development ExpenseUSD | 34,624,000Source | 30,959,000Source | 16,765,000Source |